GHB: what it does to your body and why the margin is so small

GHB has a half-life of 20 to 60 minutes, and a dose is usually largely cleared from the body within four to eight hours (PMID 22746383). That single number explains both of the things people find confusing about GHB: why the margin between effect and unconsciousness is so narrow, and why a test misses it so easily.

I consider it the most honest number in the whole GHB discussion. It explains what no warning label explains.

Below is what GHB does in the body, what a lab can and cannot say about it, and why withdrawal after regular use is treated as a medical matter.

What does GHB do to your body?

GHB is a central nervous system depressant. It acts mainly on the GABA-B receptor, the same brake your brain uses to damp down activity. The effect can be relaxation, talkativeness and lowered inhibition, and it can slide into drowsiness. As concentrations rise, that damping can turn into deep sedation.

Your body also makes small amounts of GHB itself, as a by-product of GABA metabolism. Taken from outside, the concentration is many times higher, and then it behaves like a classic sedative.

The peak in blood typically falls within one hour (PMID 22746383). After that it drops just as quickly.

That makes GHB a pharmacological outlier. It arrives fast and it leaves fast.

Why is the margin between effect and unconsciousness so small?

Because the body clears GHB so quickly, the blood concentration swings steeply rather than flattening out. Small differences in amount can therefore produce large differences in effect. A clinical toxicology review describes the range between the intended effect and serious depression of consciousness as strikingly narrow (PMID 22746383).

Absorption also varies from one occasion to the next. An empty stomach, an earlier intake that has not fully worn off, or alcohol alongside it: each shifts the curve, and not predictably.

Alcohol and other depressants add to GHB. Both suppress the same systems, so the combination can depress breathing more deeply than either substance alone.

To be clear: we name no amounts here, and the question "how much is fine" has no safe answer.

How long does GHB work and how long is it detectable?

The noticeable effect lasts roughly one and a half to three hours in most people. The detection window is barely longer: GHB leaves the blood within four to eight hours and the urine in roughly twelve hours (PMID 22746383). That is extremely short compared with almost anything else on a drug panel.

Look at the first row and then at the rest, and you see where this goes wrong. Cocaine works for a shorter time than GHB, yet stays visible for days. GHB works for longer and is often gone within half a day.

Take two men who use GHB on a Saturday night, 24 hours apart in when they are tested. One provides urine at eight on Sunday morning, the other not until Monday. The first tests positive. The second tests negative, having done exactly the same thing.

Nothing went wrong in the lab.

With a half-life of twenty to sixty minutes, GHB has usually left the urine within about twelve hours (PMID 22746383). Measure two days later and you measure nothing. With GHB, the clock matters more than the cut-off.

That has an uncomfortable implication for testing. A negative GHB result, days after a night out, says almost nothing. Not that nothing happened, only that the lab no longer found anything.

The exact windows per matrix are in our piece on how long GHB stays detectable. The comparison with other substances sits in the duration of effect versus detection window guide.

How serious is respiratory depression with GHB?

Respiratory depression is the reason GHB is well known in emergency medicine. At high concentrations the drive to breathe can be suppressed far enough that someone breathes shallowly, cannot be woken, or falls into a coma. Vomiting while consciousness is reduced makes the situation more dangerous still.

Typically people come round relatively quickly afterwards, precisely because the substance is broken down so fast. That quick recovery is easily read as reassurance, while a period of poor breathing still happened.

Combinations with alcohol or other depressants recur in most serious case reports. In the scoping review by Brennan and Van Hout, polydrug use is one of the repeated risk factors (PMID 25052883).

If someone is unresponsive after use, calling emergency services is the route. Do not wait to see whether they come round.

What does regular use do over the longer term?

Frequent use can lead to tolerance, where the same effect no longer arrives. Dependence can develop in a relatively short time, faster than many people expect. The Dutch institute RIVM described in report 340011001/2012, "Mogelijke neurotoxische effecten van GHB", that repeated episodes of deep unconsciousness may not leave the brain untouched.

The evidence base for that is still limited and partly drawn from animal work. RIVM phrases it cautiously itself, and rightly so.

What is well described is the sleep pattern: with regular use, intake often shifts into the night and rest becomes fragmented. Cognitive and mood complaints are frequently reported in user groups (PMID 25052883).

Why is GHB withdrawal a medical matter?

Because withdrawal can resemble that of other sedative drugs, and that can run a severe course. A Dutch study of 285 people with a GHB use disorder described tremor, sweating, insomnia, agitation and sudden temperature changes, among others (PMID 34073640). Stopping without supervision is therefore discouraged.

The same study found that vital signs, such as heart rate and blood pressure, correlated poorly with the other withdrawal symptoms. Someone can look calm while things are going wrong.

Addiction services manage GHB with a supervised tapering schedule. That is not something you assemble yourself, and it is not a matter of gritting your teeth.

If you want to talk it through with someone, your GP is a normal and discreet starting point.

What a lab value does and does not tell you here

A result shows exposure, nothing more. It does not tell you how much was used, not exactly when, and certainly not whether dependence is present. With GHB the short shelf life adds to that: outside the window you simply measure nothing, however the weekend went.

That is exactly why we are cautious about what a GHB test can promise. An extended 10-panel drug test makes sense if you want a broader picture of several substances over a longer period, with GHB only likely to show up shortly after use.

How a screen relates to a confirmation, and why a threshold is not an on-off switch, is covered in the cut-off value on a drug test. If something other than GHB is also in play, ketamine and the bladder and 3-MMC and the comedown are the logical follow-ups. If speed is part of the picture, the counterpart is how long speed works.

If you want to know where you stand, schedule the blood draw at a moment that matches the window you want to look at, not on the first free day that happens to suit you.

I would never read a negative GHB result as proof of anything. With this substance the clock is a stronger factor than the lab, and you deserve to hear that from a lab.

Every blood test result at Zuivertest includes a professional assessment by a BIG-registered doctor. Discuss your results with your GP before making treatment decisions.

Sources

• Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Megarbane B., "The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol", Clinical Toxicology (Phila), 2012 (PMID 22746383)
• Brennan R, Van Hout MC., "Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups", Journal of Psychoactive Drugs, 2014 (PMID 25052883)
• Wolf CJH, Beurmanjer H, Dijkstra BAG et al., "Characterization of the GHB Withdrawal Syndrome", Journal of Clinical Medicine, 2021 (PMID 34073640)
• RIVM, report 340011001/2012, "Mogelijke neurotoxische effecten van GHB" (rivm.nl)